North America organ on a chip market has dominated the global market, with a revenue share of 51.97% in 2024. Asia Pacific organ-on-a-chip market is anticipated to grow at the fastest rate of 29.11% over the forecast period Organ-on-a-chip Market Segmentation Grand View Research has segme...
Organ-on-a-chip (OOAC) is a recently emerging microfluidic-based device that can estimate the clinical outcome of tested drugs with a more physiologically based relevant model compared to that of two-dimensional in vitro cell model and animal studies. This reduces the drug failures at the ...
It is commonly used to precisely control microfluidic (10−9 to 10−18 L) fluids using channels that range in size from tens to hundreds of microns and is known as a “lab-on-a-chip” [1,2,3,4]. The microchannel is small, but has a large surface area and high mass transfer,...
Find out more about the organ-on-a-chip models, their advantages and future developments in our Topic of the Month.
As such, countries are now focusing on organ-on-a-chip technology, as studies have indicated that doing so will help to reduce the cost of drug discovery by 26%. This is because this emerging technology can support in eliminating ineffective and toxic drugs at a preclinical stage before they...
quantitative impact of organ-on-a-chip on the efficiency of pharmaceutical R&D. We surveyed experts to evaluate the technology’s impact on R&D cost in relationship to the three main efficiency drivers (costs-per-project, success rate and cycle time), per R&D phase, within a timescale of 5...
To curb the high cost of drug development, there is an urgent need to develop more predictive tissue models using human cells to determine drug efficacy and safety in advance of clinical testing. Recent insights gained through fundamenta... B Zhang,M Radisic - 《Lab on A Chip》 被引量: ...
- 《Lab on A Chip》 被引量: 50发表: 2010年 A cell-based biosensor for real-time detection of cardiotoxicity using lensfree imagingElectronic supplementary information (ESI) available: Supplementary ... A portable and cost-effective real-time cardiotoxicity biosensor was developed using a CMOS ...
Find out more about the organ-on-a-chip models, their advantages and future developments in our Topic of the Month.
Microfluidic Organ/Body-on-a-Chip Devices at the Convergence of Biology and Microengineering Recent advances in biomedical technologies are mostly related to the convergence of biology with microengineering. For instance, microfluidic devices are n... Ana,Perestrelo,Ana,... - 《Sensors》 被引量: 32...